ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

ACCC Honors Hammond, Murphy

October 19, 2001

Budget Resolution Includes Extra Money For NCI

July 2, 1982

Bristol-Myers Runs Afoul Of FDA In Attempt To Distribute Chapters of Oncology Textbook

June 19, 1992

In Brief: Earl Pollack To Retire As Head Of Seer Program; Nursing Foundation, Lederle Offer Scholarships

December 7, 1984

Higher Tobacco Tax Will Save Lives, Groups Tell Clinton, congress

January 22, 1993

New Journal Examines Claims Of Proponents Of Alternative Medicine

October 24, 1997